Form 4 for IRD Opus Genetics, Inc.
Accepted 2024-04-15 00:00:00 ET · period of report 2024-04-11 · accession 0000905148-24-001166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-15 | 2024-04-11 | IRD | Pepose Jay | Dir | A - Grant | $0.00 | +32.0K | 139.3K | +30% | $0 |
| D | 2024-04-15 | 2024-04-11 | IRD | Pepose Jay | Dir | A - Grant | $0.00 | +48.0K | 48.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-11 | A | A | 32,000 | $0.00 | 139,315 | D | — | — | (F1) Represents a grant of restricted stock units which vest on the one-year anniversary of the grant date of April 11, 2024, subject to the Reporting Person's continuing service. |
| 2 | Derivative | Stock Option (right to buy) | 2024-04-11 | A | A | 48,000 | $0.00 | 48,000 | D | $1.79 · — to 2034-04-10 | 48,000 Common Stock | (F2) The option will vest in 12 equal monthly installments beginning on May 11, 2024, subject to the Reporting Person's continuing service. |